EIRINY T ESKANDER

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism ENCINO, CA NPI 1154584183

General Payments — all program years on this page

$1,368.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 64
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $288.45 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $288.4512

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $63.332
Amgen Inc. $56.332
Abbott Laboratories $44.712
Novo Nordisk AS $34.372
Corcept Therapeutics $27.591
Insulet Corporation $24.671
Tandem Diabetes Care, Inc. $19.821
Xeris Pharmaceuticals, Inc. $17.631

By program year

Program yearAmountRecords
2018 $651.7132
2019 $231.8110
2020 $55.763
2021 $47.992
2022 $30.492
2023 $62.783
2024 $288.4512

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096946374 Novo Nordisk Inc $14.07 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097299216 Novo Nordisk Inc $20.30 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111571085 Amgen Inc. $29.57 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111571087 Amgen Inc. $26.76 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116802748 Insulet Corporation $24.67 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117733286 Corcept Therapeutics $27.59 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124873221 Abbott Laboratories $22.93 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124873223 Abbott Laboratories $21.78 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136155807 Lilly USA, LLC $33.47 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136156837 Lilly USA, LLC $29.86 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138740881 Tandem Diabetes Care, Inc. $19.82 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144593418 Xeris Pharmaceuticals, Inc. $17.63 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.